Taysha Gene Therapies, Inc. TSHA Other Financing
Other Financing at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other financing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other financing?
- Taysha Gene Therapies, Inc. (TSHA) reported other financing of $19K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s other financing changed year-over-year?
- Taysha Gene Therapies, Inc.'s other financing increased by 123.8% year-over-year, from -$80K to $19K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other financing?
- Over 2 years (2021 to 2025), Taysha Gene Therapies, Inc.'s other financing has grown at a -19.0% compound annual growth rate (CAGR), from -$514K to -$337K.
- What does other financing mean?
- Miscellaneous financing cash flows not classified in specific line items.